Status:
UNKNOWN
Measure of Acceptance of chRonic Visible sKin conditionS
Lead Sponsor:
University Hospital, Tours
Collaborating Sponsors:
INSERM UMR 1246 SPHERE
Conditions:
Acceptance of Visible Chronic Dermatological Disease
Disease Acceptance
Eligibility:
All Genders
6+ years
Brief Summary
The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with...
Detailed Description
The objective of this protocol is to validate 4 scales for evaluating the acceptance of visible chronic dermatological diseases (port wine stains, alopecia areata, vitiligo, hyperpigmentation...) with...
Eligibility Criteria
Inclusion
- Targeted pathologies:
- Flat angioma
- Primary hypopigmentation and early vitiligo
- Primary hyperpigmentation
- Refractory alopecia areata or congenital alopecia
- Persons concerned:
- Children (≥ 6 years old) suffering from one of the aforementioned pathologies
- Adults suffering from one of the above-mentioned pathologies
- Parents of children suffering from one of the aforementioned pathologies
- Parents of young adult patients if they live under the same roof
- Oral agreement for each person (major/minor) and, where applicable, one of the holders of parental authority (minor)
Exclusion
- Secondary "marks" (post-inflammatory, post-medication, post-traumatic, etc.)
- Major psychiatric disorders
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06103903
Start Date
January 1 2022
End Date
December 31 2025
Last Update
October 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital TOURS
Tours, France, 37044